Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 200 Total
WAT - Waters Corp - Stock Price Chart
TickerWAT [NYSE, S&P 500]
CompanyWaters Corp
CountryUSA
IndustryDiagnostics & Research
Market Cap22.99BEPS (ttm)10.04
P/E38.58EPS this Y-0.46%
Forward P/E30.27EPS next Y9.38%
PEG6.80EPS past 5Y7.21%
P/S7.99EPS next 5Y5.67%
P/B16.28EPS Q/Q-5.90%
Dividend-Sales Q/Q-4.33%
Insider Own0.24%Inst Own98.66%
Insider Trans-2.06%Inst Trans-2.23%
Short Float3.94%EarningsNov 01/b
Analyst Recom2.81Target Price361.75
Avg Volume361.40K52W Range234.04 - 367.21
Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FEARON RICHARD HDirectorMay 28 '24Buy332.901,000332,9001,653May 29 11:23 AM
KUEBLER CHRISTOPHER ADirectorMay 15 '24Option Exercise113.884,000455,52018,716May 16 10:55 AM
KUEBLER CHRISTOPHER ADirectorMay 15 '24Sale361.644,0001,446,56014,716May 16 10:55 AM
BADDOUR LINDADirectorMar 13 '24Sale355.54500177,7702,250Mar 14 11:08 AM
IBO - Impact BioMedical Inc - Stock Price Chart
TickerIBO [AMEX]
CompanyImpact BioMedical Inc
CountryUSA
IndustryBiotechnology
Market Cap30.82MEPS (ttm)-0.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.15EPS Q/Q-29533.33%
Dividend-Sales Q/Q-
Insider Own55.68%Inst Own-
Insider Trans0.93%Inst Trans0.99%
Short Float1.40%Earnings-
Analyst Recom-Target Price-
Avg Volume113.47K52W Range1.22 - 3.00
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DSS, INC.10% OwnerSep 18 '24Buy2.331,0002,33058,800Sep 19 07:07 PM
DSS, INC.10% OwnerSep 16 '24Buy2.6950,000134,50050,000Sep 18 08:53 PM
DSS, INC.10% OwnerSep 17 '24Buy2.407,80018,72057,800Sep 18 08:53 PM
PDEX - Pro-Dex Inc. (co) - Stock Price Chart
TickerPDEX [NASD]
CompanyPro-Dex Inc. (co)
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap122.74MEPS (ttm)0.61
P/E60.78EPS this Y136.67%
Forward P/E24.63EPS next Y5.63%
PEG-EPS past 5Y-9.20%
P/S2.28EPS next 5Y-
P/B4.03EPS Q/Q-56.66%
Dividend-Sales Q/Q41.23%
Insider Own34.90%Inst Own26.82%
Insider Trans-0.22%Inst Trans-1.99%
Short Float0.81%EarningsSep 05/b
Analyst Recom1.00Target Price30.00
Avg Volume18.49K52W Range15.70 - 34.04
Pro-Dex, Inc. engages in the design, development and manufacture of rotary drive surgical and dental instruments. The firm specializes in medical devices and services, industrial and scientific, dental and component, repairs and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Domingo Angelita RebamontanDirectorJun 24 '24Sale18.302,58547,2958,191Jun 26 08:11 PM
SABS - SAB Biotherapeutics Inc - Stock Price Chart
TickerSABS [NASD]
CompanySAB Biotherapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap35.81MEPS (ttm)-6.17
P/E-EPS this Y52.85%
Forward P/E-EPS next Y14.05%
PEG-EPS past 5Y-
P/S12.88EPS next 5Y-
P/B0.78EPS Q/Q41.92%
Dividend-Sales Q/Q207.70%
Insider Own18.88%Inst Own35.06%
Insider Trans0.00%Inst Trans-6.39%
Short Float1.07%EarningsAug 08/a
Analyst Recom1.00Target Price12.40
Avg Volume54.65K52W Range2.16 - 10.00
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sullivan Eddie JoeChief Executive OfficerDec 07 '23Buy0.881,7401,5315,232,304Dec 08 08:00 AM
King MichaelCHIEF FINANCIAL OFFICERNov 30 '23Buy0.905,0004,5005,000Nov 30 05:00 PM
Reich Samuel JExecutive ChairmanNov 29 '23Buy0.8911,0009,842219,001Nov 30 08:00 AM
TEAM - Atlassian Corporation - Stock Price Chart
TickerTEAM [NASD, NDX]
CompanyAtlassian Corporation
CountryUSA
IndustrySoftware - Application
Market Cap58.68BEPS (ttm)-1.16
P/E-EPS this Y10.84%
Forward P/E55.37EPS next Y24.76%
PEG-EPS past 5Y15.38%
P/S13.46EPS next 5Y25.30%
P/B56.60EPS Q/Q-230.31%
Dividend-Sales Q/Q20.50%
Insider Own40.09%Inst Own51.28%
Insider Trans-1.96%Inst Trans-1.21%
Short Float2.08%EarningsOct 31/a
Analyst Recom1.86Target Price253.43
Avg Volume1.99M52W Range135.29 - 258.69
Nov-01-24Upgrade KeyBanc Capital Markets Sector Weight → Overweight $260
Nov-01-24Reiterated BMO Capital Markets Market Perform $177 → $255
Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cannon-Brookes MichaelCEO, Co-FounderOct 31 '24Sale189.737,9481,507,949325,868Nov 01 05:08 PM
Farquhar ScottDirectorOct 31 '24Sale189.737,9481,507,947325,868Nov 01 05:08 PM
ANUTTHARA BHARADWAJOfficerNov 01 '24Proposed Sale188.549,1201,719,485Nov 01 04:46 PM
HEATHER MIRJAHANGIRDirectorNov 01 '24Proposed Sale188.543,000565,620Nov 01 04:46 PM
Cannon-Brookes MichaelCEO, Co-FounderOct 30 '24Sale192.567,9481,530,503333,816Oct 31 05:15 PM
ADMA - Adma Biologics Inc - Stock Price Chart
TickerADMA [NASD, RUT]
CompanyAdma Biologics Inc
CountryUSA
IndustryBiotechnology
Market Cap4.51BEPS (ttm)0.14
P/E137.77EPS this Y471.15%
Forward P/E29.57EPS next Y35.75%
PEG-EPS past 5Y38.68%
P/S13.67EPS next 5Y-
P/B23.97EPS Q/Q562.94%
Dividend-Sales Q/Q78.29%
Insider Own3.38%Inst Own80.43%
Insider Trans-10.82%Inst Trans20.13%
Short Float7.14%EarningsNov 07/a
Analyst Recom1.00Target Price19.00
Avg Volume5.16M52W Range3.35 - 21.13
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Guiheen Lawrence P.DirectorSep 09 '24Option Exercise10.809,00097,200162,941Sep 11 09:00 PM
Guiheen Lawrence P.DirectorSep 09 '24Sale18.479,000166,189153,941Sep 11 09:00 PM
Guiheen Lawrence P.DirectorSep 09 '24Proposed Sale16.269,000146,340Sep 09 09:00 PM
Kestenberg-Messina Kaitlin M.COO and SVP, ComplianceAug 30 '24Option Exercise3.8724,15093,526473,238Aug 30 09:05 PM
Kestenberg-Messina Kaitlin M.COO and SVP, ComplianceAug 30 '24Sale16.9024,150408,050449,088Aug 30 09:05 PM
CPS - Cooper-Standard Holdings Inc - Stock Price Chart
TickerCPS [NYSE, RUT]
CompanyCooper-Standard Holdings Inc
CountryUSA
IndustryAuto Parts
Market Cap255.45MEPS (ttm)-8.67
P/E-EPS this Y24.89%
Forward P/E17.56EPS next Y123.60%
PEG-EPS past 5Y-
P/S0.09EPS next 5Y-8.50%
P/B-EPS Q/Q-170.39%
Dividend-Sales Q/Q-2.12%
Insider Own3.46%Inst Own66.13%
Insider Trans0.00%Inst Trans1.24%
Short Float6.24%EarningsOct 31/a
Analyst Recom1.00Target Price20.00
Avg Volume113.82K52W Range11.24 - 20.82
Cooper-Standard Holdings, Inc. engages in the manufacture of sealing and fluid handling systems, including fuel and brake delivery and fluid transfer systems. It operates through the following segments: North America, Europe, Asia Pacific, and South America. The company was founded in 2004 and is headquartered in Northville, MI.
ETNB - 89bio Inc - Stock Price Chart
TickerETNB [NASD, RUT]
Company89bio Inc
CountryUSA
IndustryBiotechnology
Market Cap968.02MEPS (ttm)-1.97
P/E-EPS this Y-11.14%
Forward P/E-EPS next Y-13.82%
PEG-EPS past 5Y-11.24%
P/S-EPS next 5Y11.00%
P/B1.86EPS Q/Q7.22%
Dividend-Sales Q/Q-
Insider Own6.30%Inst Own96.77%
Insider Trans-0.42%Inst Trans9.17%
Short Float5.42%EarningsAug 05/a
Analyst Recom1.57Target Price31.67
Avg Volume540.47K52W Range6.88 - 16.63
89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Le-Nguyen QuocSee RemarksOct 30 '24Sale8.1227,955226,995187,796Nov 01 04:01 PM
QUOC LE-NGUYENOfficerOct 30 '24Proposed Sale8.1227,955226,972Oct 30 04:20 PM
PALEKAR ROHANChief Executive OfficerApr 01 '24Option Exercise1.9325,00048,250511,889Apr 03 04:01 PM
PALEKAR ROHANChief Executive OfficerApr 01 '24Sale10.9152,718575,153459,171Apr 03 04:01 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 04 '24Buy15.351,350,00020,722,50012,431,584Mar 06 05:40 PM
CANG - Cango Inc ADR - Stock Price Chart
TickerCANG [NYSE]
CompanyCango Inc ADR
CountryChina
IndustryAuto & Truck Dealerships
Market Cap206.43MEPS (ttm)0.18
P/E16.20EPS this Y-
Forward P/E-EPS next Y-
PEG1.46EPS past 5Y-
P/S2.43EPS next 5Y11.11%
P/B0.38EPS Q/Q180.16%
Dividend-Sales Q/Q-94.43%
Insider Own7.12%Inst Own0.62%
Insider Trans0.00%Inst Trans0.59%
Short Float0.01%EarningsNov 04/a
Analyst Recom3.00Target Price3.00
Avg Volume63.13K52W Range0.92 - 2.66
Cango, Inc. is a holding company, which engages in the development and operation of automotive transaction service platform for connecting dealers, financial institutions, and car buyers. The firm's services cover each key component of the automotive transaction value chain, including pre-sale automobile trading solutions, during-sale automotive financing facilitation services, and post-sale after-market services facilitation. The company was founded by Jia Yuan Lin and Xiao Jun Zhang in August 2010 and is headquartered in Shanghai, China.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zhang YongyiDirectorNov 08 '24Proposed Sale2.44250,000610,000Oct 31 09:47 PM
Zhang YongyiDirectorSep 04 '24Proposed Sale1.72100,000172,000Sep 03 06:14 AM
AMSC - American Superconductor Corp - Stock Price Chart
TickerAMSC [NASD, RUT]
CompanyAmerican Superconductor Corp
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap1.13BEPS (ttm)-0.04
P/E-EPS this Y2400.00%
Forward P/E54.19EPS next Y5.33%
PEG-EPS past 5Y-
P/S6.39EPS next 5Y25.00%
P/B6.08EPS Q/Q251.16%
Dividend-Sales Q/Q60.19%
Insider Own4.67%Inst Own65.92%
Insider Trans-6.05%Inst Trans20.48%
Short Float6.94%EarningsOct 30/a
Analyst Recom1.00Target Price30.33
Avg Volume1.01M52W Range6.08 - 32.70
American Superconductor Corp. engages in the provision of megawatt-scale power solutions, which improve the performance of the power grid and lower the cost of wind power. It operates through the Grid and Wind segments. The Grid segment enables electric utilities and renewable energy project developers to connect, transmit, and distribute power with efficiency, reliability, security, and affordability. The Wind segment permits the manufacturers to field wind turbines with power output, reliability, and affordability. The company was founded by Yet Ming Chiang, David A. Rudman, John B. Vander Sande, and Gregory J. Yurek on April 9, 1987 and is headquartered in Ayer, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McGahn Daniel PChairman, President and CEOJun 11 '24Sale21.6937,165806,0461,019,956Jun 12 09:09 AM
Kosiba John W JRSVP, CFO & TreasurerJun 11 '24Sale21.6832,000693,750316,136Jun 12 09:08 AM
Kosiba John W JRSVP, CFO & TreasurerMay 21 '24Sale14.8229,000429,814348,136May 23 04:33 PM
McGahn Daniel PChairman, President and CEOMay 21 '24Sale14.8220,559304,7411,057,121May 23 04:29 PM
123456781020